Calls for papers
-
California-based Elevation Pharmaceuticals has announced closing of $30 million in Series B financing for development of its lead product, EP-101, a glycopyrrolate inhalation solution for the treatment of COPD. Novo Ventures, a new investor, led… Read more . . .
-
Submit 2-3 page abstracts for oral or poster presentations by February 3, 2012 to admin@aerosol-soc.org.uk. Read more . . .
-
Drug Delivery & Formulation: Novel Technologies. Submit proposals for talks to Read more . . .
-
Wishing you a . . . Read more. Read more . . .
-
UK dry powder dispensing company VaryDose has announced the appointment of Philippe Rogueda as its Chief Technology Officer. According to the company, “Philippe brings with him many years’ experience and expertise in the powder handling… Read more . . .
-
Pharmaxis has announced that it “filed a minor resubmission with the Pharmaceutical Benefits Advisory Committee (PBAC)” for its Bronchitol mannitol dry powder inhaler for the treatment of cystic fibrosis. According to the company, the committee’s… Read more . . .
-
A Global Multinational Company headquartered in Italy, is seeking a target oriented, self-motivated individual who would be interested in working as Analytical Senior Scientist. Key Responsibilities: • Development and Validation of Drug Substance (DS) &… Read more . . .
-
Pulmatrix has presented data at the 11th US-Japan Symposium on Drug Delivery Systems in Hawaii that it says demonstrate the superiority of its iSPERSE inhalation platform over lactose formulations for combination dry powder inhalers. The… Read more . . .
-
Days after an FDA committee recommended approval of its lead product, Adasuve inhaled loxapine for the treatment of agitation in schizophrenia or bipolar disorder, Alexza Pharmaceuticals has announced that it is “exploring strategic options to… Read more . . .
-
Effective January 1 2012, the Seretide salmeterol xinafoate/fluticasone propionate Accuhaler 100 will cost £18 in the UK, a reduction of 42%. The price reduction is expected to save the National Health Service (NHS) £6.9 million… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK